Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
About this item
Full title
Author / Creator
Liang, Taizhen , Xiao, Shiqi , Wu, Ziyao , Lv, Xi , Liu, Sen , Hu, Meilin , Li, Guojie , Li, Peiwen and Ma, Xiancai
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Novel coronavirus disease 2019 (COVID-19), a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has brought an unprecedented public health crisis and continues to threaten humanity due to the persistent emergence of new variants. Therefore, developing more effective and broad-spectrum therapeutic and prophyl...
Alternative Titles
Full title
Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f8d689662b78453481a5ac280552d730
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f8d689662b78453481a5ac280552d730
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v15081666
